Phosphorylation abnormalities: NZB mice exhibit a B-cell signalling defect

Journal of Autoimmunity

Volumn 19, Issue 3, 2002, Pages 103-109

  Tuscano, Joseph M ^a   Hsu, Tom C ^b   McKnight, Hayes ^a   Ansari, Aftab A ^c   Gershwin, M Eric ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

B cells; Murine lupus; Phosphorylation pathways

Indexed keywords

ANTINUCLEAR ANTIBODY; B LYMPHOCYTE RECEPTOR; PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; LYMPHOCYTE ANTIGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL ACTIVITY; CELL ISOLATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HYPERGAMMAGLOBULINEMIA; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR OCCUPANCY; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; GENETICS; METABOLISM; NEW ZEALAND BLACK MOUSE; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALS; B-LYMPHOCYTES; MICE; MICE, INBRED NZB; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION;

EID: 0036849728     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2002.0607     Document Type: Article

References (35)

1. Theofilopoulos A.N., Dixon F.J. 1985. Murine models of systemic lupus erythematosus. Adv. Immunology. 37: 269
2. Whitmer K.J., Ansari A., Gershwin M.E. 1994. The pathogenesis of autoimmunity in New Zealand mice. Semin. Clin. Immunol. 8: 35
3. Izui S., Reininger L., Shibata T., Berney T. 1994. Pathogenesis of autoimmune hemolytic anemia in New Zealand Black mice. Crit. Rev. Oncol. Hematol. 17: 53
4. Kono D.H., Burlingame R.W., Owens D.G., Kuramochi A., Balderas R.S., Balomenos D. 1994. Lupus susceptibility loci in New Zealand mice. Proc. Natl. Acad. Sci. USA. 91: 10168
5. Vyse T.J., Drake C.G., Rozzo S.J., Roper E., Izui S., Kotzin B.L. 1996. Genetic linkage of IgG autoantibody prouction in relation to lupus nephritis in New Zealand hybrid mice. J. Clin. Invest. 98: 1762
6. Vyse T.J., Morel L.M., Tanner F.J., Wakeland E.K., Kotzin B.L. 1996. Backcross analysis of genes linked to autoantibody production in New Zealand White mice. J. Immunol. 157: 2719
7. Yoshida S., Castles J.J., Gershwin M.E. 1990. The pathogenesis of autoimmunity in New Zealand mice. Semin. Arthr. Rheum. 19: 224
8. Reininger L., Winkler T.H., Kalberer C.P., Jourdan M., Melchers F., Rolink A.G. 1996. Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZBxNZW)F1 mice. J. Exp Med. 184(3): 853
9. Benschop R.J., Cambier J.C. 1999. B cell development: Signal transduction by antigen receptors and their surrogates. Curr. Opin. Immunol. 11: 143
10. Dang A., Balasubramanyam M., Garcia Z., Raveche E., Gardner J. 1995. Altered calcium signal transduction in B-1 malignant cells. Immunol. Cell Bio. 73: 511
11. Weng W., Jarvis L., LeBien T. 1994. Signaling through CD19 activates vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/phospho-tidylinositol 3-kinase complex in human B cell precursors. J. Biol. Chem. 269: 32514
12. Zhou L., Ord D., Hughes A., Tedder T. 1991. Structure and domain organization of the CD19 antigen of human, mouse, guinea pig B lymphocytes: Conservation of the extensive cytoplasmic domain. J. Immunol. 147: 1424
13. Law C., Sidorenko S., Chandran K., Zhao Z., Shen S., Fischer E., Clark E. 1996. Cd22 associates with protein tyrosine phosphatase 1C, syk, phospholipase C-gamma (1) upon B cell activation. J. Exp. Med. 183: 547
14. Inaoki M., Sato S., Weintraub B.C., Goodnow C.C., Tedder T.F. 1997. CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J. Exp Med. 186(11): 1923
15. O'Keefe T., Williams G., Davies S., Neuberger M. 1996 Hyperresponsive B cells in CD22-deficient mice. Sci. 274: 798
16. Otipoby K., Andersson K., Draves K., Klaus S., Farr A., Kerner J., Perlmutter R., Law C., Clark E. 1996. CD22 regulates thymus-independent responses and the lifespan of B cells. Nat. 384: 634
17. Sato S., Miller A., Inaoki M., Bock C., Jansen P., Tang M., Tedder T. 1996. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: Altered signaling in CD22-deficient mice. Immun. 5: 551
18. Nitschke L., Carsetti R., Ocker B., Kohler G., Lamers M. 1997. CD22 is a negative regulator of B-cell receptor signaling. Curr. Biol. 7: 133
19. Matsuda A., Matsuzawa S., Nakamura K., Mizuno Y., Kikuchi K. 1996. Alterations in activity of protein tyrosine phosphatase SH-PTP1 in autoimmune MRL/MpJ-lpr/lpr mice. J. Biochem. 119: 329
20. Zhu T., Matsuzawa S., Mizuno Y., Kikuchi K. 1993. Alterations in activities of protein phosphatases PP1 and PP2A in T and B lymphocytes of autoimmune MRL/MpJ-lpr/lpr mice. J. Biochem. 114: 50
21. Kono D.H., Burlingame R.W., Owens D.G., Kuramochi A., Balderas R.S., Balomenos D. 1994. Lupus susceptibility loci in New Zealand mice. Proc. Natl. Acad. Sci. USA. 91: 10168
22. Vyse T.J., Drake C.G., Rozzo S.J., Roper E., Izui S., Kotzin B.L. 1996. Genetic linkage of IgG autoantibody production in relation to lupus nephritis inn New Zealand hybrid mice. J. Clin. Invest. 98: 1762
23. Vyse T.J., Morel L.M., Tanner F.J., Wakeland E.K., Kotzin B.L. 1996. Backcross analysis of genes linked to autoantibody production in New Zealand White mice. J. Immunol. 157: 2719
24. Tordai A., Franklin R.A., Patel H., Gardner A.M., Johnson G.L., Gelfand E.W. 1994. Cross-linking of surface IgM stimulates the Ras/Raf-1/MEK/MAPK cascade in human B lymphocytes. J. Biol. Chem. 269(10): 7538
25. Modur V., Zimmerman G.A., Prescott S.M., McIntyre T.M. 1996. Endothelial cell inflammatory responses to tumor necrosis factor alpha. Ceramide-dependent and independent mitogen activated protein kinase cascades. J. Biol. Chem. 271(22): 13094
26. Graves J.D., Draves K.E., Craxton A., Saklatvala J., Krebs E.G., Clark E.A. 1996. Involvement of stress-activated protein kinase and p38 mitogen-activated protein kinase in mIgM-induced apoptosis of human B lymphocytes. Proc. Natl. Acad. Sci. USA. 93(24): 13814
27. Berberich I., Shu G., Siebelt F., Woodgett J.R., Kyriakis J.M., Clark E.A. 1996. Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen activated protein kinases. Embo. Journal. 15(1): 92-101
28. Gold M.R., Aebersold R. 1994. Both phosphatidylinositol 3-kinase and phosphatidylinositol 4-kinase products are increased by antigen receptor signaling in B cells. J. Immunol. 152(1): 42
29. Berberich I., Shu G., Siebelt F., Woodgett J.R., Kyriakis J.M., Clark E.A. 1996. Cross-linking CD40 on B cell preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases. EMBO J. 15: 92
30. Paulson R.F., Vesely S., Siminovitch K.A., Bernstein A. 1996. Signaling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase SHP1. Nature Genetics. 13(3): 309
31. Gallina M.C., Steele J.K. 1991. Alleviation of autoimmune disease in MRL-lpr mice by administration of Yel9.1, a monoclonal specific for the lpr T cell antigen, LTA. J. Autoimmunity. 4(5): 755
32. Bignon J.S., Siminovitch K.A. 1994. Identification of PTP1C mutation as the genetic defect in motheaten and viable motheaten mice: A step toward defining the roles of protein tyrosine phosphatases in the regulation of hemopoietic cell differentation and function. Clin. Immunol. Immunopath. 73(2): 168
33. Sarmay G., Koncz G., Pecht I., Gergely J. 1999. Cooperation between SHP-2, phosphatidyl inositol 3-kinase and phosphoinositol 5-phosphatase in the Fc gamma RIIb mediated B cell regulation. Immunol. Lett. 68(1): 25
34. Maresco D.L., Osborner J.M., Cooney D., Coggeshall K.M., Anderson C.L. 1999. The SH2-containing 5′-inositol phosphatase (SHIP) is tyrosine phosphorylated after Fc gamma receptor clustering in monocytes. J. Immunol. 162: 6458
35. Marchetto S., Fournier E., Beslu N., Aurran-Schleinitz T., Dubreuil P., Borg J.P., Birnbaum D., Rosnet O. 1999. SHC and SHIP phosphorylation and interaction in response to activation of the FLT3 receptor. Leukemia 13(9): 1374